Development and validation of a deep learning-based pathomics signature for prognosis and chemotherapy benefits in

Shenghan Lou1, Yanming Huang1, Fenqi Du1

  • 1Department of Oncology Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

PubMed
Abstract